Introducing Spotlight Series from theAmerican Heart Association

Complimentary CME/CE programs on the newest, evidence-based
measures to prevent cardiovascular disease.

About Spotlight Series

Complimentary CME/CE presentations delivered
by American Heart Association experts at hospital grand rounds, nationwide.

Heart disease is the number one killer of men and women in the United States, and nearly 70% of the population, over 60 years of age, are personally affected by cardiovascular disease. Educating healthcare professionals on the latest science, and current guideline recommendations can help to improve patient care and promote better outcomes.


The American Heart Association promises to be the most trusted provider of quality and relevant professional education by delivering best practice and emerging scientific knowledge to healthcare professionals and resources to translate that knowledge for the prevention, diagnosis and treatment of cardiovascular disease and stroke.


Spotlight Series, which began in 2008, offers free, case-based presentations designed to educate healthcare providers on evidence-based practices. The target audience includes internists, family practice physicians and other primary care physicians, cardiologists, nurses, pharmacists, physician assistants and other clinicians involved in the treatment of patients with or at risk for cardiovascular disease. The AHA is the accredited provider for this program and CME/CE credit is available to all physician, nurse and pharmacist attendees.

By incorporating Spotlight Series presentations into your institution's educational programming, together we can help build healthier lives, free of cardiovascular diseases and stroke.

Why Request a Spotlight Series?

IT'S FREE! There is no cost to your institution.




By AHA Experts

Did we mention IT'S FREE?

Available Series

Please select a series below to view more information

Spotlight Series: Racial and Ethnic Disparities in Hypertension

African Americans are significantly more likely than whites to be diagnosed with hypertension, yet are significantly less likely to achieve blood pressure goals despite equal or even higher levels of treatment. Medication adherence, economic issues, patient/physician communication, and differences in antihypertensive efficacy in blacks all contribute to the disparities. It is crucial that clinicians identify opportunities for improvement in the management of hypertension in their African-American patients and integrate those opportunities into their practices. For more information please visit  Racial and Ethnic Disparities in Hypertension

This activity is supported by an independent medical educational grant from Novartis Pharmaceuticals.

Request This Topic

Spotlight Series: Anticoagulants and Antithrombotic Controversies for Stroke Prevention in Atrial Fibrillation

Anticoagulation is an important consideration in the management of atrial fibrillation. The goal of this accredited education program will be to provide healthcare professionals with very specific guidance related to what is known and what is not known about novel anticoagulants; identifying the most appropriate patients for their use, discerning their role in patients with non-valvular AF, and preventing stroke and the growing medical care costs associated with atrial fibrillation and stroke. Please click here for more information.

This activity is supported by independent medical educational grants from the Bristol-Myers Squibb/Pfizer Pharmaceuticals Partnership and Boehringer Ingelheim Pharmaceuticals, Inc.

Request This Topic

Contact Us

Your feedback is important to us. For all inquiries, comments, and suggestions regarding the Spotlight Series, please complete the form below.

Send us a Message
Other Methods
  • Address:
    7272 Greenville Ave.
    Dallas, TX 75231
  • Phone number:
  • E-mail: